|
|
Hypoxia and Cancer
Sponsored by
APS Hypoxia Group
Oxidative Stress/Hypoxia Track
Monday, April 30 — 8:00-10:00 AM
Washington, DC Convention Center — Room 146C
|
| Chaired: |
Gregg L. Semenza, Johns Hopkins Univ.
Sch. of Med. |
Human cancers are characterized by intratumoral hypoxia
that results from dysregulated cell proliferation. Physiological
responses triggered by hypoxia impact on all critical aspects of cancer
progression, including immortalization, transformation, differentiation,
genetic instability, angiogenesis, metabolic adaptation, autocrine
growth factor signaling, invasion, metastasis, and resistance to
therapy. This symposium will focus on the cellular and molecular
mechanisms by which cancer cells coopt adaptive physiological responses
to hypoxia, particularly those that are mediated by the transcriptional
activator hypoxia-inducible factor 1.
|
8:00 AM |
The role of hypoxia-inducible factor 1 in human
cancer.
Gregg L. Semenza, Johns Hopkins Univ. Sch. of Med.
|
|
8:30 AM |
The role of hypoxia in Akt-mediated melanocyte
transformation.
Marianne Broome-Powell, Stanford Univ.
|
|
9:00 AM |
The role of hypoxia in tumor cell
differentiation.
Lorenz Poellinger, Karolinska Inst.
|
|
9:30 PM |
Mechanisms of hypoxia-induced resistance to
radiation therapy.
Mark W. Dewhirst, Duke Univ. Med. Ctr.
|
|
|